#ThisPlaceIsSpecial because of our award-winning researchers trailblazing patient care and outcomes. Congratulations to Dr. Natalie Coburn on being awarded a Tier 1 Canada Research Chair (CRC) in Cancer Outcomes. Read more about the honour: bit.ly/3PhvYqQ

We are pleased to share that Dr. Shunji Nagai has been appointed to the role of surgical director of Liver #Transplantation and surgical director of our Living Donor Liver Transplant Program. Congrats, Dr. Nagai!

With #Match2024 and #Carms2024 here UpSurge wants to present the next batch of surgeons! We had the pleasure of collaborating with Next Surgeon program and Toronto Community Housing for 2 wknds of simulation. Enjoy 🎥 Thanks Temerty Advanced Surgical Education & Sim Centre and Allan Okrainec for hosting us! Temerty Medicine

Day 1⃣ of #AHPBA24 is here☀️ Lots of great content! Don't miss: ⏰2:15PM: Future of HPB surgery, on liver transplantation for #CRLM with @sapisochin ⏰3:00PM: Mentorship & physician wellness Sean Cleary, T Reichman, Marwan Abouljoud, MD, FACS, MMM, CPE IHPBA AHPBA SoMe4HPB Cdn General Surgeons CSSO

⁦Gonzalo Sapisochin⁩ highlighting the current advances for transplant for metastatic colon cancer ⁦AHPBA⁩ ⁦Jenna Whitrock⁩ ⁦ASTS⁩

Amazing talk by Marwan Abouljoud, MD, FACS, MMM, CPE on wellness and balance as the inaugural Paul Greig Lecture at AHPBA annual meeting UHN Sprott Department of Surgery Ajmera Transplant Centre UHN UofT General Surgery

Results of #PRICE2 trial presented at #AHPBA24 by Guillaume Martel: hypovolemic phlebotomy vs usual care for major hepatectomy 4⃣4⃣8⃣pts Significant ⬇️🩸transfusion No adverse events New standard of care for major hepatectomy?

Results of #HELIX trial presented at #AHPBA24 by Paul Karanicolas: TXA vs placebo for hepatectomy 1⃣3⃣8⃣4⃣pts No difference in primary outcome of🩸transfusion But increased complications (related to VTE) TXA not for use in hepatectomy⚠️

Outstanding lecture and AHPBA Presidential term by Sean Cleary Canadian Hepato-Pancreato-Biliary Association IHPBA “The Patients Come First”

Dr. Gonzalo Sapisochin, a leader in the field discussing exciting ways to get liver cancer patients to LT as the field of transplant oncology continues to evolve. ⁦@sapisochin⁩ ⁦ILTS⁩

That's a wrap on National #NursingWeek at UHN! #TeamUHN's 5,600 nurses (across all UHN sites, including West Park Healthcare Centre) are at the very heart of our system. Thank you for always putting the needs of patients first!

Good luck to all Ontario #GeneralSurgery PGY5s on The Royal College exams today! You got this! 👍UofTGenSx U of T Department of Surgery McMaster General Surgery Niagara McMaster Surgery Western General Surgery Residency Program uOttawaGenSurg Queen's General Surgery NOSM University | Université EMNO Resident Doctors CAGS Residents Cdn General Surgeons

Great discussion by Dr. Lee w shoutout to @sapisochin liver tx program in Toronto!

Clinical impact of ctDNA to track minimal residual disease in CRC. Hopes and limitations ESMO Open doi.org/10.1016/j.esmo… 👏very comprehensive review 👉undeniable prognostic role, but still some work to do to intergrate as tool for optimal personalized treatment strategies

Congrats to ON #GeneralSurgery PGY5+ grads of 2024 and welcome PGY1s!👏👏 We'd like your input on how we can better support you. Take our survey: rebrand.ly/ll4l6g9 | The Royal College U of T Department of Surgery McMaster Surgery Western General Surgery Residency Program uOttawaGenSurg Queen's General Surgery NOSM University | Université EMNO

We start the last session of the day on precision therapeutic strategies in biliary tract cancers. Dr. Gonzalo Sapisochin discusses the definition of resectable disease. #PrecisionBTCNet #ENSCCA #Krakow2024 🔬🇵🇱

Glad to be participating in a virtual symposium with Liver/Intestinal Community of Practice - AST re: Clinical Research Indication for Transplant Oncology in #ColorectalCancer co-chaired by Alexandra Shingina, M.D., M.Sc. Anjana Pillai Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center #cancer #CancerResearch #crcsm

Thanks to all the amazing patients, surgeons, and researchers who made this trial possible. TXA did not reduce bleeding or blood transfusion but increased periop complications after liver resection. ⁦JAMA⁩ jamanetwork.com/journals/jama/…

Delighted to get our work accepted in the leading journal of transplantation American Journal of Transplantation! Herein we tackle how long recipients of living donor liver transplantation survive, how survival has improved in recent eras and patient and center-factors associated with this.

🏔️ A new milestone has been reached! 🔵 Out now in The Lancet Transmet Trial 💥 Liver Transplantation + chemotherapy superior to chemo alone in permanently unresectable CRLM 📈 5-year overall survival 56·6% vs. 12.6% A new era has begun?! 🧐 sciencedirect.com/science/articl…